Long-term molecular complete remission with IFN-α in Ph+ adult acute lymphoid leukemia patients

Leukemia

Volumn 22, Issue 8, 2008, Pages 1617-1618

  Piccaluga, P P ^a   Martinelli, G ^a   Isidori, A ^b   Malagola, M ^c   Rondoni, M ^d   Paolini, S ^a   Amabile, M ^a   Iacobucci, I ^a   Baccarani, M ^a   Visani, G ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Ravenna Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ALPHA INTERFERON; BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; HYBRID PROTEIN; IMATINIB; MERCAPTOPURINE; MESSENGER RNA; METHOTREXATE; METHYLPREDNISOLONE; P190 BCR ABL PROTEIN; P210 BCR ABL PROTEIN; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DRUG DOSE REDUCTION; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; LEUKEMIA REMISSION; MULTIPLE CYCLE TREATMENT; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 49449105662     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.10     Document Type: Article

References (10)

1. Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR et al. Acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2002, 162-192.
2. Piccaluga PP, Martinelli G, Rondoni M, Visani G, Baccarani M. Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia. Expert Opin Biol Ther 2006; 6: 1011-1022.
3. Visani G, Martinelli G, Piccaluga P, Tosi P, Amabile M, Pastano R et al. Alpha-interferon improves survival and remission duration in P-190BCR-ABL positive adult acute lymphoblastic leukemia. Leukemia 2000; 14: 22-27.
4. Zinzani PL, Bendandi M, Visani G, Gherlinzoni F, Frezza G, Merla E et al. Adult lymphoblastic lymphoma: Clinical features and prognostic factors in 53 patients. Leuk Lymphoma 1996; 23: 577-582.
5. Amabile M, Giannini B, Testoni N, Montefusco, V, Rosti G, Zardini C et al. Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia. Haematologica 2001; 86 252-259.
6. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003; 17: 2318-2357.
7. Visani G, Isidori A, Malagola M, Alberti D, Capdeville R, Martinelli G et al. Efficacy of imatinib mesylate (STI571) in conjunction with alpha-interferon: Long-term quantitative molecular remission in relapsed P-190(BCR-ABL)-positive acute lymphoblastic leukemia. Leukemia 2002; 16: 2159-2160.
8. Ottmann OG, Druker BJ, Sawyers CL, Goldman JM, Reiffers J, Silver RT et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965-1971.
9. Piccaluga. PP, Paolini S, Martinelli G. Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Cancer 2007; 110: 1178-1186.
10. Wassmann B, Scheuring U, Pfeifer H, Binckebanck A, Kabisch A, Lubbert M et al. Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). Leukemia 2003; 17: 1919-1924.